EMPOWER CTA
Total Payments
$257,501
Transactions
21
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $257,501 | 21 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $240,515 | 11 | 93.4% |
| Consulting Fee | $16,986 | 10 | 6.6% |
Top Doctors Receiving Payments for EMPOWER CTA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Rochester, MN | $257,501 | 21 |
Ad
Manufacturing Companies
- ACIST MEDICAL SYSTEMS, INC. $257,501
Product Information
- Type Drug
- Total Payments $257,501
- Total Doctors 0
- Transactions 21
About EMPOWER CTA
EMPOWER CTA is a drug associated with $257,501 in payments to 0 healthcare providers, recorded across 21 transactions in the CMS Open Payments database. The primary manufacturer is ACIST MEDICAL SYSTEMS, INC..
Payment data is available from 2019 to 2019. In 2019, $257,501 was paid across 21 transactions to 0 doctors.
The most common payment nature for EMPOWER CTA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($240,515, 93.4% of total).